MIF and ovarian carcinoma: Furthermore, a proteomic analysis indicated the utility of MIF in diagnostic screening, and a multiplex test combining MIF with other biomarkers, including CA-125 and prolactin, demonstrated high sensitivity (95.3%) and specificity (99.4%) for ovarian cancer detection.